Highest-materiality recent filing
RenaissanceRe Q2 2026 net income $654.2M, operating income $547.8M; combined ratio 72.8%
Net income available to common shareholders $654.2M ($15.48 diluted EPS); operating income $547.8M ($12.92 diluted EPS).
RenaissanceRe announces CFO and CPO retirement; Matthew Neuber to become CFO in 2027
Robert Qutub, EVP and CFO, to retire Dec 31, 2026; Matthew Neuber, currently SVP, Senior Financial Officer and Treasurer, will succeed as EVP, CFO, and Treasurer effective Jan 1, 2027.
RenaissanceRe shareholders approve 2026 LTIP, elect directors, pass say-on-pay
1.25M common shares authorized under new 2026 Long-Term Incentive Plan, replacing the 2016 plan.
RenaissanceRe Q1 2026 net income $284.5M, operating income $590.5M, combined ratio 73.0%
Net income available to common $284.5M ($6.57/diluted share); operating income $590.5M ($13.75/diluted share).
RenaissanceRe reports Q4 net income $751.6M ($16.75 EPS), full year ROE 25.9%
Full year 2025 net income available to common shareholders $2.6B; operating income $1.9B; return on equity 25.9%.
Extended availability end date of $320M secured LC facility to Dec 31, 2026; expiry to Dec 31, 2027.
RenaissanceRe Q3 net income $907.7M; operating EPS $15.62; combined ratio 68.4%
Net income available to common shareholders $907.7M, diluted EPS $19.40; operating income $733.7M, operating EPS $15.62.
Net income available to common shareholders $826.5M ($17.20 diluted EPS); operating income $594.6M ($12.29 diluted EPS).
RenaissanceRe publishes 2024 Financial Condition Report; no material updates
Financial Condition Report for year ended December 31, 2024 published June 3, 2025.
Elected Loretta J. Mester, Henry Klehm III, Valerie Rahmani, Carol P. Sanders, and Cynthia Trudell as directors; each received >37M votes for.
RenaissanceRe Q1 net income $161M but operating loss $69.8M on $702.8M catastrophe hit
Net income $161.1M ($3.27 diluted EPS); operating loss $(69.8)M ($(1.49) diluted) from $702.8M net negative large loss events including California Wildfires.
RenaissanceRe JV DaVinciRe prices $300M 5.950% senior notes due 2035
$300M aggregate principal at 5.950% due 2035; expected close March 5, 2025.
RenaissanceRe closes $500M 5.800% senior note offering due 2035
Issued $500M aggregate principal of 5.800% Senior Notes due 2035.
RenaissanceRe prices $500M of 5.800% senior notes due 2035
$500 million aggregate principal amount of 5.800% Senior Notes due 2035.
RenaissanceRe Q4 net loss $198.5M on $630M mark-to-market losses; full-year net income $1.8B
Q4 net loss attributable to common $198.5M ($3.95 diluted EPS); operating income $406.9M ($8.06 diluted EPS).
RenaissanceRe extends secured LC facility; availability now to Dec 2025, expiry Dec 2026
Facility size up to $320M, with potential increase to $350M.
RenaissanceRe appoints former Cleveland Fed President Loretta Mester to board; Gray retires
Brian Gray retired as director effective Nov 6, 2024 after 11 years; no disagreement with management.
RenaissanceRe Q3 net income $1.2B; operating income $540M; combined ratio 84.8%
Net income available to common shareholders $1.2B ($22.62/diluted share); operating income $540.3M ($10.23/share).
RenaissanceRe enters $250M standby letter-of-credit facility with Nordea Bank
Aggregate L/C capacity of $250M under uncommitted, unsecured facility.
RenaissanceRe Q2 net income $495M, EPS $9.41; gross premiums up 29%
Operating income $650.8M ($12.41 per diluted share); annualized operating ROE 28.2%.
RenaissanceRe publishes 2023 Financial Condition Report on website and files with BMA
Report covers business performance, governance, risk, solvency, and capital management for year ended Dec 31, 2023.
RenaissanceRe annual meeting: all director nominees elected, say-on-pay and auditor approved
Class II directors Brian Gray, Duncan Hennes, Kevin O'Donnell elected with >46.8M votes for each.
RenaissanceRe Q1 net income $364.8M, operating income $636.4M, combined ratio 77.9%
Net income available to common $364.8M ($6.94 diluted EPS); operating income $636.4M ($12.18 diluted EPS).
RenaissanceRe Q4 net income $1.6B (EPS $30.43); operating income $623M (EPS $11.77)
Q4 net income available to common shareholders $1.6B, diluted EPS $30.43; annual net income $2.5B.
RenaissanceRe provides Validus Holdings financials; Validus 2022 net loss $160.5M
Validus Holdings 2022 net loss $160.5M, revenue $2.03B; 2021 net income $49.5M, revenue $2.27B.
RenaissanceRe increases secured letter of credit facility to $200M
Fourth Amendment raises secured LC cap to $200M from $150M for five applicant subsidiaries.
RenaissanceRe grants CEO O'Donnell $12M performance equity; additional $3M to four execs
CEO O'Donnell receives performance-based restricted stock with target value $12M; 60% tied to TBV growth over 2023-2026.
RenaissanceRe amends credit facilities; reduces LC commitment to $225M, ups secured limit to $320M
RRL reduces letter of credit facility from $275M to $225M; term extended to 4 years from Dec 31, 2023 expiry notice.
RenaissanceRe Q3 net income $194M; completes Validus Re acquisition
Q3 net income available to common shareholders $194.0M ($3.80 diluted EPS); operating income $422.3M ($8.33 diluted EPS).
RenaissanceRe closes acquisition of Validus Re for ~$2.985B in cash and stock
Total consideration ~$2.985B: $2.735B cash plus 1,322,541 shares valued at $189.03 each ($250M).
Q2 2023 net income to common shareholders $191M ($4.09 diluted EPS); operating income $407.4M ($8.79 diluted EPS).
RenaissanceRe names Robin Lang permanent Group Chief Risk Officer; Ian Branagan steps down
Robin Lang appointed permanent Group CRO effective Sept 1, 2023; had served as interim since April 2023.
RenaissanceRe prices $750M 5.750% Senior Notes due 2033 to fund Validus acquisition
Issued $750M of 5.750% Senior Notes due 2033; offering closed June 5, 2023.
RenaissanceRe posts FY2022 Financial Condition Report to website
FCR for year ended Dec 31, 2022 published on www.renre.com under 'Investors' > 'Financial Reports'.
RenaissanceRe prices $192/share offering of 6.3M common shares to fund Validus acquisition
Priced 6,300,000 common shares at $192.00 per share; overallotment of 945,000 shares exercised in full.
RenaissanceRe files SPA to acquire Validus Holdings and Validus Specialty from AIG
Acquisition of Validus Holdings (Bermuda) and Validus Specialty (Delaware) from AIG subsidiaries for cash and newly issued RenaissanceRe shares.
RenaissanceRe to acquire Validus Re from AIG for $2.985 billion
Total consideration $2.985B: $2.735B cash plus $250M common shares; AIG retains 95% of reserve development.
RenaissanceRe launches 6.3M share offering to fund Validus acquisition from AIG
Offering of 6,300,000 common shares; underwriters can purchase up to 945,000 additional shares.
RenaissanceRe elects four Class I directors, approves say-on-pay at 2023 AGM
Class I directors elected: David C. Bushnell, James L. Gibbons, Shyam Gidumal, Torsten Jeworrek, each with at least 86% of votes cast for.
RenaissanceRe Q1 2023 net income $564.1M, operating income $360.0M, ROE 46.6%
Net income $564.1M ($12.91 EPS); operating income $360.0M ($8.16 operating EPS).
RenaissanceRe CRO Ian Branagan takes compassionate leave; Robin Lang named interim
Ian Branagan, EVP and Group CRO, on compassionate leave from April 1 to July 3, 2023.
RenaissanceRe amends standby LC agreement; adds $150M secured LC option, removes unsecured option
Third Amendment to Amended and Restated Standby Letter of Credit Agreement with Wells Fargo dated Feb 22, 2023.
RenaissanceRe Q4 net income $448.1M, annual net loss $1.1B on weather losses; premiums grow 21%
Q4 net income $448.1M ($10.27/diluted share); operating income $322.2M ($7.33/share).
RenaissanceRe renews $500M credit facility to Nov 2027 with ESG pricing option
New $500M revolving credit facility matures Nov 18, 2027; can be increased to $700M.
RenaissanceRe appoints David Marra Group CUO and Ross Curtis Chief Portfolio Officer
David Marra named EVP, Group Chief Underwriting Officer and CEO of Renaissance Reinsurance U.S. Inc., effective January 1, 2023.
RenaissanceRe Q3 net loss $825M; Ian impact $648M
Net loss $825.3M ($19.27/diluted share); operating loss $396.7M ($9.27/share).
RenaissanceRe estimates $650M net negative Q3 impact from catastrophes, mostly Hurricane Ian
Hurricane Ian accounts for ~$540M of the estimated $650M net negative impact on Q3 2022 results.
RenaissanceRe Q2 net loss $324.9M, operating income $238.1M; combined ratio 78.3%
Net loss attributable to common shareholders $324.9M ($7.53 diluted EPS); operating income $238.1M ($5.51 operating EPS).
RenaissanceRe publishes 2021 Financial Condition Report on website and with BMA
FCR for year ended Dec 31, 2021 posted on renre.com and filed with Bermuda Monetary Authority.
RenaissanceRe shareholders approve amended 2016 LTIP; adds 925K shares
Shareholders approved First Amended and Restated 2016 Long-Term Incentive Plan, increasing share reserve by 925,000 common shares.
As of January 1, 2027, Matthew Neuber, the Company’s current Senior Vice President, Senior Financial Officer and Corporate Treasurer, will be Executive Vice President, Chief Financial Officer and Corporate Treasurer.
Robert Qutub, the Executive Vice President and Chief Financial Officer of RenaissanceRe Holdings Ltd. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his intention to retire as Executive Vice President and Chief Financial Officer of the Company, effective December 31, 2026
Ross Curtis, the Executive Vice President and Chief Portfolio Officer of the Company, notified the Board of his intention to retire as Executive Vice President and Chief Portfolio Officer of the Company, effective as of the Effective Date.
On November 6, 2024, Brian G. J. Gray, a member of the RenaissanceRe Holdings Ltd. (the “Company”) Board of Directors (the “Board”), announced his retirement from the Board effective November 6, 2024.
the Board has appointed Loretta J. Mester as a Class II director, effective November 6, 2024, to serve until the Company’s 2027 Annual General Meeting of Shareholders, or until her earlier resignation or removal.
Robin Lang will assume the role of Group Chief Risk Officer of the Company on a permanent basis on September 1, 2023
Ian Branagan will be stepping down as Group Chief Risk Officer and Executive Vice President for personal reasons after a period of compassionate leave, effective September 1, 2023.
Robin Lang, SVP and Head of Risk Oversight, who has been with the Company for 22 years, will serve as Interim Chief Risk Officer.
Ian Branagan, Executive Vice President and Group Chief Risk Officer of the Company, will take a compassionate leave of absence beginning April 1, 2023
On November 9, 2022, RenaissanceRe Holdings Ltd. (the “Company”) and Ross A. Curtis, the Company’s Executive Vice President and Group Chief Underwriting Officer and a current Named Executive Officer of the Company, mutually determined that Mr. Curtis assume the role of Executive Vice President and Chief Portfolio Officer of the Company and transition from the role of Chief Underwriting Officer, effective January 1, 2023.
Shyam Gidumal has been nominated to stand for election as an independent director of the Company at the Company’s Annual General Meeting of Shareholders in May 2022
Jean Hamilton will retire from the Board.
Max materiality 0.90 · Median 0.60 · Most common event earnings